VYGR
Voyager Therapeutics Inc
NASDAQ: VYGR · HEALTHCARE · BIOTECHNOLOGY
$3.73
+2.47% today
Updated 2026-04-30
Market cap
$224.69M
P/E ratio
—
P/S ratio
5.57x
EPS (TTM)
$-2.04
Dividend yield
—
52W range
$3 – $6
Volume
0.7M
Voyager Therapeutics Inc (VYGR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-296.50%
Operating margin
-172.40%
ROE
-48.30%
ROA
-24.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | — | $-7.67M | — | — | — |
| 2014 | $0.00 | $-16.32M | — | — | — |
| 2015 | $17.33M | $-29.67M | 100.00% | -116.85% | -171.18% |
| 2016 | $14.22M | $-40.19M | 100.00% | -290.43% | -282.65% |
| 2017 | $10.13M | $-70.70M | 100.00% | -709.06% | -697.56% |
| 2018 | $7.62M | $-88.29M | 100.00% | -1,195.63% | -1,158.79% |
| 2019 | $104.39M | $-40.83M | 100.00% | -49.51% | -39.11% |
| 2020 | $171.13M | $36.74M | 36.45% | 16.00% | 21.47% |
| 2021 | $37.41M | $-66.03M | 100.00% | -196.76% | -176.49% |
| 2022 | $40.91M | $-46.41M | 100.00% | -124.27% | -113.45% |
| 2023 | $250.01M | $132.33M | 63.13% | 48.80% | 52.93% |
| 2024 | $80.00M | $-65.00M | 100.00% | -104.11% | -81.25% |
| 2025 | $40.37M | $-119.72M | 100.00% | -326.56% | -296.53% |